These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 22890122)
1. Successful treatment of γ-heavy-chain disease with rituximab and fludarabine. Inoue D; Matsushita A; Kiuchi M; Takiuchi Y; Nagano S; Arima H; Mori M; Tabata S; Yamashiro A; Maruoka H; Oita T; Imai Y; Takahashi T Acta Haematol; 2012; 128(3):139-43. PubMed ID: 22890122 [TBL] [Abstract][Full Text] [Related]
2. [Successful treatment of Bing-Neel syndrome using combination therapy with fludarabine and rituximab]. Nagaharu K; Miyazami K; Imai H; Tamura A; Umino A; Fujieda A; Sugimoto Y; Yamaguchi M; Masuya M; Katayama N Rinsho Ketsueki; 2014 Dec; 55(12):2423-8. PubMed ID: 25744044 [TBL] [Abstract][Full Text] [Related]
3. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia. Robak T; Lech-Maranda E; Robak P Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624 [TBL] [Abstract][Full Text] [Related]
4. Lymphoplasmacytic lymphoma with IgA hypergammaglobulinemia and liver involvement. Polprasert C; Wongchitrat C; Assanasen T; Prayongratana K J Med Assoc Thai; 2009 Jun; 92 Suppl 3():S65-8. PubMed ID: 19702069 [TBL] [Abstract][Full Text] [Related]
5. Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Fermand JP; Brouet JC; Danon F; Seligmann M Medicine (Baltimore); 1989 Nov; 68(6):321-35. PubMed ID: 2509855 [TBL] [Abstract][Full Text] [Related]
6. Fludarabine may overcome resistance to rituximab in IgM-related neuropathy. Koya J; Iwata A; Nakamura F; Nagashima Y; Ichikawa M; Tsuji S; Kurokawa M J Neurol Sci; 2012 Apr; 315(1-2):150-2. PubMed ID: 22236889 [TBL] [Abstract][Full Text] [Related]
7. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy? Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V; Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786 [TBL] [Abstract][Full Text] [Related]
8. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment. Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067 [TBL] [Abstract][Full Text] [Related]
9. Analysis of hepatitis B surface antibody titers in B cell lymphoma patients after rituximab therapy. Pei SN; Ma MC; Wang MC; Kuo CY; Rau KM; Su CY; Chen CH Ann Hematol; 2012 Jul; 91(7):1007-12. PubMed ID: 22273839 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal free light chains can be found in heavy chain diseases. López-Anglada L; Puig N; Díez-Campelo M; Alonso-Ralero L; Barrena S; Aparicio MA; Gutiérrez NC; García-Sanz R Ann Clin Biochem; 2010 Nov; 47(Pt 6):570-2. PubMed ID: 20930031 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemia. Kawano Y; Nakama T; Hata H; Kimura E; Maruyoshi N; Uchino M; Mitsuya H J Neurol Sci; 2010 Oct; 297(1-2):101-4. PubMed ID: 20673674 [TBL] [Abstract][Full Text] [Related]
12. Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas: phase 2 study of the Italian Lymphoma Foundation. Ferrario A; Pulsoni A; Olivero B; Rossi G; Vitolo U; Tedeschi A; Merli F; Rigacci L; Stelitano C; Goldaniga M; Mannina D; Musto P; Rossi F; Gamba E; Baldini L Cancer; 2012 Aug; 118(16):3954-61. PubMed ID: 22179904 [TBL] [Abstract][Full Text] [Related]
13. Fludarabine combination therapy is highly effective in first-line and salvage treatment of patients with Waldenström's macroglobulinemia. Tam CS; Wolf MM; Westerman D; Januszewicz EH; Prince HM; Seymour JF Clin Lymphoma Myeloma; 2005 Sep; 6(2):136-9. PubMed ID: 16231852 [TBL] [Abstract][Full Text] [Related]
14. [Gamma-heavy chain disease associated with MALT lymphoma of the duodenum]. Ieko M; Kohno M; Ohmoto A; Notoya A; Fukazawa Y; Yasukouchi T; Sawada K; Koike T Rinsho Ketsueki; 1998 Jul; 39(7):512-8. PubMed ID: 9750459 [TBL] [Abstract][Full Text] [Related]
15. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia. Del Giudice I; Matutes E; Osuji N; Parry-Jones N; Swansbury J; Catovsky D Haematologica; 2005 Feb; 90(2):268-70. PubMed ID: 15710588 [TBL] [Abstract][Full Text] [Related]
16. Gamma heavy chain disease (γ-HCD) as iatrogenic immunodeficiency- associated lymphoproliferative disorder: Possible emergent subtype of rheumatoid arthritis-associated γ-HCD. Tsunemine H; Zushi Y; Sasaki M; Nishikawa Y; Tamura A; Aoyama Y; Kodaka T; Itoh T; Takahashi T J Clin Exp Hematop; 2019; 59(4):196-201. PubMed ID: 31866621 [TBL] [Abstract][Full Text] [Related]